Scalable microfluidic fabrication of optimized phospholipid nanocarriers for enhanced topical bioavailability: Analytical QbD integration and ex vivo skin permeation assessment.

Authors

Giulia Bucciarelli, Giulia Curzi, Mattia Tiboni, Annalisa Aluigi, Andrea Heinz, Luca Casettari

Published in

International journal of pharmaceutics: X. Volume 11. Pages 100563. Epub May 06, 2026.

Abstract

18β-Glycyrrhetinic acid (18β-GA), the primary bioactive metabolite of glycyrrhizin (GL) derived from licorice root, exhibits anti-inflammatory, antioxidant, and antimicrobial activities, as well as excellent biocompatibility, making it a promising candidate for the treatment of dermatological disorders. However, its poor water solubility limits topical bioavailability. In this study, an Analytical Quality by Design (QbD) approach was established to develop and optimize nanocarriers loaded with 18β-GA, to improve skin penetration while providing sustained and controlled release. Ethosomes, glycerosomes, and glycethosomes were produced using an innovative and customized 3D-printed microfluidic chip, resulting in vesicles with controlled size, narrow polydispersity, high encapsulation efficiency, and high physicochemical stability through a reproducible and cost-effective process. A Design of Experiments (DoE) strategy was used to identify critical formulation parameters and develop a predictive mathematical model. The three optimized formulations were incorporated into an alginate hydrogel, exhibiting shear-thinning behavior, ideal for topical application. Ex vivo permeation studies revealed that the optimized nanocarriers modulate the skin delivery of 18β-GA, with formulation composition significantly influencing drug distribution profiles. The systems reduced rapid diffusion into the receptor phase and promoted controlled drug release, supporting localized delivery. Drug accumulation within the skin layers indicated that release from the formulation represents the rate-limiting step. The hydrogels exhibited prolonged drug release and improved skin contact, enabling sustained and uniform topical application. Process scalability was successfully achieved using a peristaltic pump, highlighting the robustness, low-cost nature, and industrial feasibility of the proposed microfluidic approach for controlled topical drug delivery.

PMID:
42180586
Bibliographic data and abstract were imported from PubMed on 14 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.